
OSE Immunotherapeutics SA
PAR:OSE

Intrinsic Value
The intrinsic value of one
OSE
stock under the Base Case scenario is
12.99
EUR.
Compared to the current market price of 5.9 EUR,
OSE Immunotherapeutics SA
is
Undervalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
OSE Immunotherapeutics SA
Fundamental Analysis


Revenue & Expenses Breakdown
OSE Immunotherapeutics SA
Balance Sheet Decomposition
OSE Immunotherapeutics SA
Current Assets | 69.9m |
Cash & Short-Term Investments | 16.7m |
Receivables | 4.1m |
Other Current Assets | 49m |
Non-Current Assets | 54m |
Long-Term Investments | 6.4m |
PP&E | 3.4m |
Intangibles | 44m |
Other Non-Current Assets | 192k |
Free Cash Flow Analysis
OSE Immunotherapeutics SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
OSE Immunotherapeutics SA
Revenue
|
83.4m
EUR
|
Operating Expenses
|
-39.7m
EUR
|
Operating Income
|
43.7m
EUR
|
Other Expenses
|
-6.3m
EUR
|
Net Income
|
37.4m
EUR
|
OSE Profitability Score
Profitability Due Diligence
OSE Immunotherapeutics SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Score
OSE Immunotherapeutics SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
OSE Solvency Score
Solvency Due Diligence
OSE Immunotherapeutics SA's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Score
OSE Immunotherapeutics SA's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OSE Price Targets Summary
OSE Immunotherapeutics SA
According to Wall Street analysts, the average 1-year price target for
OSE
is 16.83 EUR
with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.
Dividends
Current shareholder yield for OSE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
OSE
stock under the Base Case scenario is
12.99
EUR.
Compared to the current market price of 5.9 EUR,
OSE Immunotherapeutics SA
is
Undervalued by 55%.